Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 3, Partially Blinded, Randomized, Multi-Center, Controlled Study to Evaluate Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Meningococcal Serogroup B Vaccine
V72P13
NCT00657709
Infections, Meningococcal
Phase 3
 
An extension study V12P13E1 was conducted. An analysis-ready dataset is not available for this study. There is no GSK Clinical Study Register entry for this study.
October 2015

Powered by ideaPoint, Inc.